Skip to main content
Lifecare ASA logo

Lifecare ASA — Investor Relations & Filings

Ticker · LIFE ISIN · NO0013355859 LEI · 254900D88MYGZ7JD5P39 OL Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2024-06-14 Capital/Financing Update
Country NO Norway
Listing OL LIFE

About Lifecare ASA

https://lifecare.no/

Lifecare ASA is a clinical-stage medical sensor company specializing in the development of nanotechnology for medical applications. Its core activity involves creating miniaturized, implantable, and long-term nanobiosensors for the continuous monitoring of various body analytes. The company's primary focus is on developing a sensor for correct and continuous glucose monitoring to improve diabetes management. The business model is based on developing and licensing its proprietary sensor technology to facilitate the production and sale of advanced medical devices.

Recent filings

Filing Released Lang Actions
Lifecare ASA: Final results of the Rights Issue and resolution to increase the share capital for settlement of the underwriting commission
Capital/Financing Update Classification · 1% confidence The document is titled "LIFECARE ASA: FINAL RESULTS OF THE RIGHTS ISSUE AND RESOLUTION TO INCREASE THE SHARE CAPITAL FOR SETTLEMENT OF THE UNDERWRITING COMMISSION". It details the outcome of a Rights Issue, including the number of shares subscribed, allocation details, expected proceeds, and the process for warrant allocation and trading. This content directly relates to changes in the company's capital structure and fundraising activities. This aligns perfectly with the definition for Capital/Financing Update (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it concerns a specific, major financing event.
2024-06-14 English
Lifecare ASA: Final results of the Rights Issue and resolution to increase the share capital for settlement of the underwriting commission
Capital/Financing Update Classification · 1% confidence The document is an announcement titled "Lifecare ASA: Final results of the Rights Issue and resolution to increase the share capital for settlement of the underwriting commission." It details the outcome of a rights issue, including the number of shares subscribed, gross proceeds raised (approximately NOK 90 million), allocation details, and plans for issuing warrants as underwriting compensation. This content directly relates to fundraising, capital structure changes, and the finalization of a financing activity. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it concerns a specific, major capital event.
2024-06-14 English
Lifecare ASA: Preliminary results of the Rights Issue
Capital/Financing Update Classification · 1% confidence The document is titled "LIFECARE ASA: PRELIMINARY RESULTS OF THE RIGHTS ISSUE" and details the outcome of a rights issue, including the number of shares subscribed for and the timeline for allocation and payment. A rights issue is a specific type of corporate action related to raising capital or changing the capital structure. This directly aligns with the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it concerns a specific financing event.
2024-06-13 English
Lifecare ASA: Preliminary results of the Rights Issue
Share Issue/Capital Change Classification · 1% confidence The document is titled "Lifecare ASA: Preliminary results of the Rights Issue" and details the subscription results, allocation timeline, and payment due dates for a rights issue (a form of capital raising/financing activity). It explicitly mentions the subscription price, gross proceeds, and the issuance of new shares and warrants. This content directly relates to fundraising and capital structure changes. Therefore, the most appropriate classification is Capital/Financing Update (CAP). It is not a full 10-K, an earnings release (ER), or a simple announcement of a report (RPA/RNS), but the substance is about the capital transaction itself.
2024-06-13 English
LIFE Successful in-vitro quality testing of sensor
Environmental & Social Information Classification · 1% confidence The document is a short announcement dated June 13th, 2024, from Lifecare ASA regarding the successful in-vitro quality testing of a sensor. It references a prior stock exchange notification and concludes with contact information and a statement about information submission pursuant to the Securities Trading Act and MAR Article 19. This type of brief, material, non-financial operational update that is not a standard periodic report (10-K, IR, ER) or a specific corporate action (DIV, CAP, MANG) fits best under the general regulatory announcement category, as it is a disclosure required by market regulations (MAR Article 19). Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a specific, non-standard regulatory disclosure that doesn't match the other defined categories like Director's Dealing (DIRS) or Earnings Release (ER). The document length is very short (1546 chars), suggesting it is an announcement rather than a full report.
2024-06-13 English
LIFE Successful in-vitro quality testing of sensor
Regulatory Filings Classification · 1% confidence The document is a short announcement dated June 13th, 2024, from Lifecare ASA regarding the successful in-vitro quality testing of a sensor. It references a prior stock exchange notification and concludes with contact information and a statement that the information was submitted pursuant to the Securities Trading Act § 5-12 and MAR Article 19 no. 3. This structure—a brief update on a specific operational event, often referencing regulatory requirements but not being a full financial report (like 10-K or IR)—suggests it is a general regulatory announcement. Since it doesn't fit clearly into specific categories like DIV, DIRS, or ER, and it is not an announcement *about* publishing a report (RPA), the most appropriate fallback category for a general, non-standard regulatory update is Regulatory Filings (RNS). The document length (1618 chars) supports it being a brief filing rather than a comprehensive report.
2024-06-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.